Alexion Pharmaceuticals, Inc.
Company Name: Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the development of treatments for severe and ultra-rare diseases. The company’s Soliris® is a terminal complement inhibitor designed to treat atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company’s metabolic franchise includes enzyme replacement therapies … Read more